Blog — OcuTerra

OcuTerra Insights

Welcome to OcuTerra Insights, our forum to keep you updated on the latest happenings at OcuTerra and in the industry. Hear from the OcuTerra team as well as eye care providers and patients as we work to drive innovation that has the potential to change the treatment paradigm for debilitating eye diseases, such as diabetic retinopathy (DR).

Early and Active Interventions: A Substantial Opportunity to Change the Way Diabetic Retinopathy is Treated

MacDougall CreativeJanuary 30, 2024

Looking Forward to a Landmark Year: Making Our DR:EAM a Reality in 2024

Brad GoodDecember 19, 2023

American Diabetes Month: An Opportunity to Improve Awareness of Diabetic Retinopathy

Brad GoodNovember 29, 2023

New Opportunities, New Challenges: Emerging Factors Shaping the Future of Clinical Trials in Ophthalmology and Beyond

Brad GoodOctober 26, 2023

The Diabetic Retinopathy Pandemic: Considerations for Comprehensively Addressing this Condition

Brad GoodSeptember 27, 2023

The Growing Prevalence of Diabetic Retinopathy: Why Patients with Diabetes Should Receive Eye Exams Early and Often

Brad GoodAugust 24, 2023

Advances in Screening Technology – Essential Tools for Managing Diabetic Retinopathy

Brad GoodJuly 26, 2023

Topical Therapy – Empowering Patients to Administer Treatment at Home

Brad GoodJune 29, 2023

New Developments in Eye Drop Formulation: How OTT166 is Purpose-engineered to Reach the Retina

Brad GoodMay 25, 2023

Moving Beyond the Standard of Care: How Novel Approaches Could Become the Future of Diabetic Retinopathy Treatment

Brad GoodApril 20, 2023